Increasing the Efficiency of Pharmaceutical Manufacturing

Sudhakar Singh, Managing Editor

The global pharmaceutical manufacturing market is anticipated to grow at a Compound Annual Growth Rate of 11.34 percent until 2028. The pharmaceutical sector has undergone a tremendous transformation with the emergence of advanced technologies, cost-effective as well as highly-efficient manufacturing approaches. Furthermore, increasing investment flow in this segment has impacted the market growth positively. As the trends reshape the pharmaceutical startup segment, we have come up with this special issue that focuses exclusively on this niche segment.

The cover story of this issue features Axxelent Pharma Science. Focused on Contract Development and Manufacturing of pharmaceutical products is Axxelent Pharma Science, a specialty pharma company focused on B2B offerings via CDMO, Partnerships, and outlicensing for regulated markets. Well positioned in the space of CDMO, Axxelent offers comprehensive solutions for various dosage forms from development to manufacturing of Oral Solid Dosage, Injectables, Ophthalmic, Oral liquids and Topicals.

The issue also features Cosworth Biocare - a privately held pharmaceutical company that is widening the range of products offered to industry by adding into the traditional forms. Focused strongly on Innovation and Research, the company is present in many areas spread across the specialties including gastrointestinal, heamatinics, multivitamin, anti-infectives and antibiotics and immunologicals. Reading on, you will find more stories on the other top players in this field.

Keeping tabs on this market, we have shortlisted the top 10 companies that have exhibited an unrelenting pursuit for excellence. By proving their dedication to fulfilling customer expectations and contributing to the market’s evolution through their innovative disposition, these companies are blazing a trail for others to follow and setting an example for them.

We look forward to receiving your feedback and suggestions.

© 2024 India Pharma Outlook. All Rights Reserved.